Clinical trials recruiting in Villingen-Schwenningen, Germany
11
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 5Phase 4 1Not applicable 5
Conditions recruiting in Villingen-Schwenningen, Germany
Recruiting trials in Villingen-Schwenningen, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
- Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- The "Global Paradise System" Registry
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Common questions
How many clinical trials are recruiting in Villingen-Schwenningen, Germany?
11 recruiting trials have at least one study site in Villingen-Schwenningen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.